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Abstract
Background
Madurella mycetomatis is the most prevalent causative agent of eumycetoma in Sudan, an
infection characterized by the formation of grains. Many patients are exposed to the causa-
tive agent, however only a small number develop infection.M.mycetomatis contains chitin
in its cell wall, which can trigger the human immune system. Polymorphisms in the genes
encoding for the chitin-degrading enzymes chitotriosidase and AMCase were described,
resulting in altered chitinase activity. We investigated the association between 4 of these
polymorphisms and the incidence ofM.mycetomatismycetoma in a Sudanese population.
Methodology
Polymorphisms studied in 112 eumycetoma patients and 103 matched controls included a
24-bp insertion in the chitotriosidase gene (rs3831317), resulting in impaired chitinase activ-
ity and single nucleotide polymorphism (SNP) in the AMCase gene (rs61756687), resulting
in decreased AMCase activity. Also, a SNP (rs41282492) and a 10-bp insertion in the
5’UTR region of the AMCase gene (rs143789088) were studied, both resulting in increased
AMCase activity. DNA was isolated from blood and genotypes were determined using
PCR-RFLP.
Principal Findings
Histological staining proved the presence of chitin in the fungal grain. The polymorphism
resulting in decreased chitotriosidase activity was associated with increased odds of eumy-
cetoma (odds ratio 2.9; p = 0.004). No association was found for the polymorphisms in the
genes for AMCase (all p>0.05).
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Conclusion
Decreased chitotriosidase activity was associated with increased risk ofM.mycetomatis
mycetoma.
Author Summary
Madurella mycetomatismycetoma is a chronic fungal infection, resulting frequently in
mutilating lesions. The causative agents are found in soil, however, many people are
exposed but most do not develop mycetoma. Characteristic for mycetoma is that the fungus
organizes itself in a grain once inside the body. Here we showed that this grain contains chi-
tin. The immune system of the host will try to eliminate the grains by producing cytokines
and enzymes, including the chitin-degrading chitinases. We showed that both human chiti-
nases AMCase and chitotriosidase bind to fungal chitin in the grain. We also investigated 4
polymorphisms in the genes for these chitinases, and we found that a polymorphism in the
gene for chitotriosidase, resulting in enzyme inactivity, was associated with increased risk
for mycetoma. Based on these findings, we hypothesized that chitotriosidase is important
in the pathogen-eliminating immune response, resulting in clearance of the infection. We
assumed that absence of chitotriosidase results in increased AMCase production and thus
in grain formation. In this study we identified a risk factor for the development ofM.myce-
tomatismycetoma, however the disease is multifactorial and other factors also play a role.
Introduction
Mycetoma is a chronic infectious granulomatous disease that is frequently reported in tropical
and subtropical climates between 30°N and 15°S of the equator. Mycetoma can be caused by
bacteria (actinomycetoma) and fungi (eumycetoma), though the fungusMadurella mycetoma-
tis is the most common causative agent in the world [1,2]. In Sudan it accounts for over 70% of
all mycetoma cases [1]. The lower extremities are affected most, though other sites of the body
can be affected as well [1]. After traumatic inoculation of the causative agent into the subcuta-
neous tissue, usually in the sole of the foot, the disease progresses and invades the deep struc-
tures and the skin. Multiple nodules and sinuses discharging pus are formed and grains
develop. In the grains, the fungal mycelium is embedded in hard brown matrix containing mel-
anin. This grain is thought to protect the fungus from the host immune system.
In endemic areas in Sudan,M.mycetomatis DNA was found in the soil [3] and antibodies
against mycetoma causative agents have been detected in the majority of the inhabitants in
these areas [4]. However, it is not clear why only a minority of the exposed humans develop
overt clinical infection. Several environmental and patient-related factors have been described
to influence the risk for the development of mycetoma, including concurrent schistosomiasis
[5]. Furthermore, several associations with genetic polymorphisms in genes involved in hor-
mone synthesis [6] and parts of the immune system, including collagenases and gelatinases
were reported [4, 7, 8]. However, the role of chitinases in eumycetoma caused byM.mycetoma-
tis was not investigated previously.
Infection withM.mycetomatis often results in fungal grain development in the tissue. The
exact composition of the grain is not known. Ibrahim et al reported that the grains contain
melanin, heavy metals, proteins and lipids, resulting in a cement matrix in which the mycelium
is embedded [9]. Probably, the grain also contains chitin, since chitin is one of the cell wall
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components of many fungi. Around the fungal grain, the host’s innate immune system mounts
an inflammatory response, resulting in a reactive granuloma laden with neutrophils, macro-
phages and other inflammatory cells [10]. Chitinases are part of the innate immune system
and, in general, their production by macrophages and other cells is upregulated by the host’s
tissue exposure to chitin. Chitinases seem to play a role in allergic and infectious diseases
caused by chitin-bearing organisms [2, 11, 12], however the exact role of these enzymes in
pathogenesis is yet to be elucidated. Chitinases hydrolyze chitin, which is the main component
of the fungal cell wall. Decreased chitinase activity could, therefore, result in an enhanced sus-
ceptibility towards infections by chitin bearing fungi. Currently, two true chitinases are known
in humans: chitotriosidase and acidic mammalian chitinase (AMCase)[13]. Polymorphisms in
the genes for these chitinases have been described that are associated with either increased or
decreased enzyme activity [12,14–17]. Impaired or decreased activity of either one or both of
these chitinases could result in increased susceptibility towards fungal infections including
eumycetoma. The aim of this study is to investigate the role of chitinase activity in the develop-
ment of mycetoma caused byM.mycetomatis. We hypothesized that chitotriosidase and
AMCase polymorphisms, resulting in decreased chitinase activity, would be found more fre-
quently in mycetoma patients than in controls.
Methods
Study population
Individuals presenting at Mycetoma Research Center, Khartoum between 2001 and 2008, were
eligible for inclusion, when the diagnosis ofMadurella mycetomatismycetoma was confirmed.
People living in the same endemic regions were included as controls. The demographic features
are given in Table 1. Retrospectively, genotypes were determined of 112Madurella mycetoma-
tis infected patients and 103 healthy endemic controls, matched for sex and age. Whole blood
was stored at -80°C until processing. DNA was isolated from whole blood of these subjects
using the MagNA Pure LC DNA Isolation kit—Large Volume (Roche Diagnostics Nederland
BV, Almere, the Netherlands) according to the manufacturer’s instructions. DNA was stored
at -20°C until processing. Tissue of the foot and of the grain was obtained in 1998 from Suda-
nese subjects, infected withM.mycetomatis.
Genotyping
PubMed Library was searched for publications describing polymorphisms in the chitotriosi-
dase gene and in the AMCase gene. We included only polymorphisms that were described
Table 1. Study population demographic features.
Characteristic Mycetoma patients (n = 112) Endemic controls (n = 103)
Gender (male/female) 79/33 77/26
Mean duration in years (range) 6.9 (1–27) N/A
Mycetoma lesion site* Foot 87 N/A
Hand 12 N/A
Lower leg 14 N/A
Mycetoma lesion size Small (<5 cm) 55 N/A
Moderate (5–10 cm) 20 N/A
Massive (>10 cm) 38 N/A
* One patient had two lesions, one of the foot and one of the hand
doi:10.1371/journal.pntd.0004061.t001
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elsewhere to result in an alteration (either increase or decrease) of the chitinase enzymatic
activity. PCR primers, amplification conditions and restriction enzymes used in this study are
shown in Table 2. We purchased all enzymes at Fermentas (Thermo Fisher Scientific, Wal-
tham, USA). Enzymes were used according to manufacturer’s guidelines. We determined geno-
types by polymerase chain reaction restricted fragment length polymorphism (PCR-RFLP).
PCR products were run at a 2.5% metaphor gel in 90 minutes. Two different investigators
assessed genotypes separately.
Immunohistochemistry
Tissue biopsies were fixed in formalin, embedded in paraffin and processed for immunohisto-
chemical evaluation. To determine if the antibodies directed against human AMCase and chit-
otriosidase did not cross-react with any fungal proteins, heat-fixed in vitro grownM.
mycetomatis hyphae were stained with the same protocol. Histologic sections (coupes) were
deparaffinised in xylene, then rehydrated in decreasing concentrations of ethanol. Haematoxy-
lin and eosin staining was used as standard staining. Calcofluor-white staining was used to
visualize chitin, according to manufacturer’s guidelines. Coupes were washed in aquadest and
incubated with 25 μM calcofluor-white (Molecular Probes, Leiden, The Netherlands) for 30
minutes at 37°C in the dark. Afterwards, coupes were washed in aquadest and assessed by fluo-
rescent microscopy.
Presence of chitinase was determined as described previously [2]. First, endogenous peroxi-
dase was blocked in methanol with 0.3% H2O2 and non-specific binding sites were blocked
with rabbit or goat serum. Subsequently, coupes were incubated overnight with rabbit poly-
clonal antibody directed against chitotriosidase (H-66, 1:75, Santa Cruz Biotechnology, Santa
Cruz, USA) or with goat polyclonal antibody directed against AMCase (Y-14, 1:50, both Santa
Cruz Biotechnology, Santa Cruz, USA). As a control, a goat polyclonal IgG antibody was used,
directed against swine IgM (A100-100A, 1:50, Bethyl Laboratories, Montgomery, USA). From
the VectaStain1 Elite ABC kit (Vector Laboratories Burlingame, CA, USA), we used anti-rab-
bit IgG or anti-goat IgG as a secondary antibody and the coupes were developed using the pro-
tocol from the kit. Haematoxylin was used as counter staining.
Ethics statement
Written informed consent was obtained from patients and controls, according to guidelines
from the medical ethical committee at Soba University Hospital, Khartoum, Sudan. The study
protocol was approved by this medical ethical committee.
Table 2. PCR conditions for the different polymorphisms.
Polymorphism Primer sequence
(5’-> 3’)
PCR program Restriction
endonuclease
Activity Length (bp) Ref
Chitotriosidase 24-bp
insertion
F: agctatctgaagcagaag 4’ 94°C + 40x (30” 94°C + 30” None Normal 124 bp [14, 19,
20]
rs 3831317 R: ggagaagccggcaaagtc 55°C + 30” 72°C) + 7’ 72°C Decreased 148 bp
AMCase A50G F: gtctcaccctgccttctttg 4’ 94°C + 40x (30” 94°C + 30” ApoI (XapI) Normal 175 + 91 [21]
rs 61756687 R: acccaattctcctcggaaag 58°C + 30” 72°C) + 7’ 72°C Decreased 266
AMCase A290G F: ctctgcctaccagctgacat 4’ 94°C + 40x (30” 94°C + 30” TaqI Normal 256 + 81 + 69 [17]
rs 41282492 R: gccattccgcaccgtataca 58°C + 30” 72°C) + 7’ 72°C Increased 256 + 150
AMCase 10-bp insertion
5’UTR
F: ctgaccacagtatctaaacag 4’ 94°C + 40x (30” 94°C + 30” BfaI Normal 392 + 59 [16]
rs 143789088 R: ctgaccacagtatctaaacag 58°C + 30” 72°C) + 7’ 72°C Increased 308 + 94 + 59
doi:10.1371/journal.pntd.0004061.t002
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Statistical analysis
Pearson’s χ2 test was used to verify the Hardy-Weinberg equilibrium. Differences in allele fre-
quencies were determined using the two-sided Fisher’s exact test (GraphPad Prism Software,
San Diego, USA). A p-value of p< 0.05 was considered significant.
Results
Mycetoma grains caused byMadurella mycetomatis contain chitin and
chitinase
Tissue sections of the fungal grain caused byM.mycetomatis are shown in Fig 1. The sections
were stained using haematoxylin and eosin (HE) (Fig 1A), grocott’s methenamine silver stain
(Fig 1B) and calcofluor-white stain (Fig 1C). In Fig 1A it is clearly seen that the grain itself con-
tains cement material. The hyphae are embedded within this cement material (Fig 1B). In Fig
1C, fungal chitin is stained by calcofluor-white [18]. This figure shows that the chitin is mainly
found in the hyphae inside the grain. The cement material itself is not stained. Since chitin is
present in the hyphae inside the grain, we hypothesized that the host produces chitinases, in
reaction to exposure to chitin. Thus, tissue sections were stained for chitotriosidase and for
AMCase (Fig 2). The presence of chitinases is shown by a red color, which was mainly located
in the grain on the fungal hyphae and not in the cement component of the grain. This seems
consistent with the presence of the chitin itself, which was also mainly found on the fungal
hyphae and not in the cement material. We also found that both chitotriosidase and AMCase
were found in the tissue surrounding the fungal grain, however both chitinases concentrated in
the grain. The staining reaction for chitotriosidase was specific, since no binding of the chito-
triosidase specific antibodies was noted on in vitro grown fixatedM.mycetomatis hyphae. In
contrast, binding of the AMCase specific antibodies was noted on some in vitro grown, fixated
M.mycetomatis hyphae, although the staining was less intense than that inside the grain.
Therefore it is plausible that not only chitotriosidase but also AMCase are indeed binding to
the hyphae inside the mycetoma grain.
Polymorphisms in the genes for chitinases cause a risk for infection with
M.mycetomatis
We subsequently investigated whether genetic polymorphisms that resulted in either increased
or decreased activity of either chitinase, were associated with an increased risk for invasive
Fig 1. Tissue sections of Mycetoma foot, showing the fungal grain.Magnification 400x. (A) Haematoxylin and eosin staining. The grain, consisting of
cement and fungal hyphae, is colored red. Around the grain, a zone with neutrophils is visible. (B) Grocott’s methenamine silver staining. The hyphae inside
the grain are stained black. (C) Calcofluor white staining. Chitin is stained by calcofluor white staining [18]. This photo illustrates that hyphae inside the grain
are stained, and not the cement component of the grain.
doi:10.1371/journal.pntd.0004061.g001
Chitinases inMadurella mycetomatisMycetoma
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004061 September 2, 2015 5 / 11
fungal mycetoma disease. Exactly 215 Sudanese subjects were included in the study and were
genotyped. Of these, 112 subjects had active mycetoma disease and were classified as patients,
and 103 subjects were healthy controls. Genotype frequencies are shown in Table 3. The geno-
type distribution for all polymorphisms was consistent with the Hardy Weinberg equilibrium.
The 24-bp insertion in the chitotriosidase gene is associated with
invasive mycetoma
In the gene encoding for chitotriosidase, a 24-bp insertion in exon 10 was described previously
[12, 14, 19, 20]. It was described elsewhere that chitotriosidase activity is reduced when patients
are heterozygous for this insertion and completely absent when they were homozygous for this
allele [12, 14]. Among the patients, 1/112 (0.9%) was homozygous for the 24-bp insertion and
27/112 (24.1%) were heterozygous. Among the controls, 1/103 (1.0%) was homozygous for the
insertion and 8/103 (7.8%) were heterozygous. The insertion containing allele was found signif-
icantly more frequently in the patients than in the control group (p = 0.004). Based on these
data, the 24-bp insertion in the chitotriosidase gene does increase the risk for invasive myce-
toma disease caused byM.mycetomatis (odds ratio 2.9; 95% CI 1.4–6.1).
Neither the A50G and the A290G SNP, nor the 10-bp insertion in the
5’UTR region of AMCase is associated with invasive mycetoma
Several SNPs in the AMCase genes were described previously, resulting in either increased or
decreased AMCase activity [16, 17, 21]. As shown in table 2, we studied two SNPs (A50G and
A290G) and one 10-bp insertion in the 5’UTR region of the AMCase gene. Allele frequencies
of A50G and A290G in the patients were similar to those in the controls (p = 0.65; odds ratio
1.2; 95% CI 0.6–2.1; and p = 0.72; odds ratio 1.1; 95% CI 0.7–1.8, respectively). Furthermore,
Fig 2. Tissue sections of Mycetoma foot stained for chitotriosidase and for AMCase.Magnification
100x (A and C) and 400x (B and D). (A) and (B): Chitotriosidase. (C) and (D): AMCase. Presence of both
enzymes is shown by red color. The grain is clearly visible and colored red diffusely. Inside the grain, fungal
hyphae are stained more intensely, showing an increased presence of chitotriosidase and AMCase around
the fungal hyphae.
doi:10.1371/journal.pntd.0004061.g002
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no difference was found in the presence of the 10-bp insertion between patients and controls
(p = 0.72; odds ratio 1.1; 95% CI 0.7–1.8).
Discussion
Madurella mycetomatis is the most prevalent causative agent of eumycetoma worldwide and in
Sudan in particular [1]. Many inhabitants of Sudan are exposed to this causative agent, how-
ever few of them develop mycetoma. Currently, the predisposing factors for mycetoma are not
known, but some genetic polymorphisms have been associated with the development of myce-
toma [4, 6, 7].
In this paper, we first showed that chitin is present in theM.mycetomatis grain and that
two human chitinases are found in the vicinity of this grain, in reaction to exposure toM.myce-
tomatismycetoma. Both AMCase and chitotriosidase seemed to concentrate on the chitin-con-
taining fungal hyphae, a phenomenon that was previously found in rats infected with
Aspergillus fumigatus [2]. Since in both mycetoma and in A. fumigatus infected tissue AMCase
and chitotriosidase concentrated on chitin-containing fungal hyphae, it needed to be deter-
mined if this was not due to cross-reaction of fungal proteins with the antibodies used. Staining
in vitro grownM.mycetomatis hyphae with an antibody for chitotriosidase showed no staining
on the hyphae. Also, no staining of A. fumigatus hyphae occurred [2], making it likely that the
chitotriosidase antibodies were specifically directed against mammalian chitotriosidase and
that fungi expressed no proteins which share epitopes with this enzyme. However, it should be
kept in mind that in vitro grown fungi could express different proteins than could be expressed
in a grain. In contrast to the specificity of the chitotriosidase antibody, the AMCase antibody
seemed less specific. When stained with the AMCase antibody, some staining of the in vitro
grownM.mycetomatis hyphae was noted. This was not the case for A. fumigatus hyphae [2].
Apparently, a protein with an epitope similar to that of AMCase is located on some fungal
Table 3. Distribution of polymorphisms in the genes for chitotriosidase and for AMCase.
Gene Polymorphism Genotype Enzyme
activity*
Patients (%)
n = 112
Controls (%)
n = 103
HWE** p-
value
p-
value
Odds ratio (95% CI
interval)
Chitotriosidase 24-bp
insertion
Wildtype Normal 84 (75%) 94 (91%) 0.106 0.004 2.9 (1.4–6.1)
Heterozygous 24-bp
insertion
Decreased 27 (24%) 8 (8%)
Homozygous 24-bp
insertion
Impaired 1 (1%) 1 (1%)
AMCase A50G AA Normal 92 (82%) 83 (81%) 0.940 0.647 1.1 (0.7–1.8)
AG Normal 14 (13%) 19 (18%)
GG Decreased 6 (5%) 1 (1%)
AMCase A290G AA Normal 74 (66%) 67 (65%) 0.657 0.717 1.2 (0.6–2.1)
AG Normal 30 (27%) 33 (32%)
GG Increased 8 (7%) 3 (3%)
AMCase 10-bp insertion
5’UTR
Wildtype Normal 73 (65%) 66 (64%) 0.578 0.720 1.1 (0.7–1.8)
Heterozygous 10-bp
insertion
Normal 31 (28%) 34 (33%)
Homozygous 10-bp
insertion
Increased 8 (7%) 3 (3%)
*Genotype associated with an impaired, normal or decreased enzyme activity according to previous publications [14, 16, 17, 19–21]
**Hardy Weinberg Equilibrium (HWE) as assessed by Pearson’s χ2 test. A p-value of >0.05 was associated with equilibrium.
doi:10.1371/journal.pntd.0004061.t003
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hyphae when grown in vitro. Therefore the AMCase stained in the tissue samples of the
patients could be the result of both expressed human AMCase and a protein of fungal origin.
Since the staining was more intense in the tissue sections, we feel that it is likely that AMCase
was indeed present.
Next to demonstrating that AMCase and chitotriosidase were present at the site of infection,
we also provided evidence that a polymorphism in the gene for chitotriosidase, resulting in
impaired enzyme activity, significantly increased the risk for the development of eumycetoma.
Increased or decreased activity of the alternative human chitinase, AMCase, did not have a sig-
nificant influence on the risk for eumycetoma. InM.mycetomatismycetoma, chitotriosidase is
apparently more crucial than AMCase. Although chitotriosidase and AMCase are both chiti-
nases, the cleavage site of both chitinases differs. Chitotriosidase is an exochitinase, whereas
AMCase is an endochitinase, referring to the site where the enzyme cleaves the chitin chain
[22]. Apparently, exochitinase activity is more important in the prevention of mycetoma than
endochitinase activity. This is supported by the fact that in certain diseases an association was
found with only one chitinase and not with both. In genetic association studies conducted in
patients with bronchial asthma, an association was reported with only one chitinase, and not
with both of them [21, 23, 24], indicating that both chitinases may have the same substrate, but
have a distinct function in humans. Chitin and the produced chitotriosidase seem to be impor-
tant in the development of the mycetoma grain. Since many mycetoma patients have the wild
type chitinases associated with normal levels and activity of these enzymes, however, polymor-
phisms in these enzyme-encoding genes are clearly not the only factors that determine the risk
forM.mycetomatismycetoma.
Many previous reports showed that polarization of the immune response seems to play a
role in the development of mycetoma [4, 7, 25–28]. The development of mycetoma is associ-
ated with a Th2 response. Based on immunohistochemistry studies in various mycetoma caus-
ative agents, it appeared that the cytokine pattern surrounding the mycetoma grain is a Th2
response. IL-10 and IL-4, both Th2-associated cytokines, were highly expressed around the
fungal grain [7, 26, 27]. A different study showed that after stimulation of peripheral blood
mononuclear cells (PBMCs) with mycetoma antigens, a Th2 response developed in mycetoma
patients and a Th1 response developed in healthy endemic controls [25]. Indirect evidence for
a Th2 response was also found in the association between schistosomiasis, associated with a
Th2 response, and eumycetoma [5]. Not only cytokines, but also other mediators matching
Th2 response were reported in mycetoma.
Sandler et al [28] showed that mice with a Th2 response have increased expression of matrix
metalloproteinases (MMPs) and of tissue inhibitor of MMP-1 (TIMP-1). Furthermore,
AMCase was induced in Th2-polarized mice [28], which was confirmed by several other stud-
ies [29–31]. Furthermore, Geneuglijk et al confirmed that MMP-2 and MMP-9 were expressed
in the mycetoma lesion [8]. In this paper we also demonstrated that AMCase and chitotriosi-
dase are expressed in the mycetoma lesion.
In contrast to AMCase, which is induced in a Th2 response, chitotriosidase is produced in
the environment of a Th1 response [32]. In our study we showed that impaired function of
chitotriosidase increases the risk to develop mycetoma.
Since Elagab et al already demonstrated that the PBMCs of healthy endemic controls pro-
duce Th1 cytokines when exposed toM.mycetomatis antigens, it is likely that they also produce
high levels of chitotriosidase in order to eliminateM.mycetomatis. In individuals with a geno-
type resulting in impaired chitotriosidase activity, elimination ofM.mycetomatis could be less
efficient, leading to the development of a mycetoma lesion. More research is needed to unravel
the exact role of the host in the development of the mycetoma grain.
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Based on the data of this study and of other studies, we created the following hypothesis.
When a host is exposed toM.mycetomatis, it will try to eliminate the pathogen. Most individu-
als will respond with a Th1 polarized response. In this response acute inflammation develops,
chitotriosidase is produced and no grain is formed. When the response is mainly Th2-polar-
ized, a chronic inflammatory process in which both chitotriosidase and AMCase are produced,
results in the formation of granulomas with grains. The chronic exposure to fungal material in
combination with the Th2 response also results in an increase in MMPs, which further modu-
lates the collagen capsule surrounding the grain [2, 8, 28]. Polymorphisms in the genes for IL-
10, CCL-5 and TIMP-1 were shown to increase the risk for mycetoma [7, 8]. Chitinases
degrade the chitin component of the fungal cell wall [2]. A polymorphism in the gene for chito-
triosidase results in impaired enzyme activity [14], which in its turn results in an increased risk
of developingMadurella mycetomatismycetoma, as we showed in this paper.
In conclusion, in this study we demonstrated that the grain caused byMadurella mycetoma-
tis, contains chitin. The human immune system produced both AMCase and chitotriosidase in
the vicinity of this grain. Only the 24-bp insertion in the gene for chitotriosidase was associated
with the development of mycetoma caused byM.mycetomatis.
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